Analyst picks & changes
Robert Fine of Nomura Equity Research initiated coverage of Creative BioMolecules Inc. with a "buy." He said CBMI shares have
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
Robert Fine of Nomura Equity Research initiated coverage of Creative BioMolecules Inc. with a "buy." He said CBMI shares have